# Alaunos Therapeutics, Inc.: Form SCHEDULE 13D, filed May 14, 2025

- Company: [Alaunos Therapeutics, Inc.](/companies/tcrt.md) (CIK 1107421)
- Form: SCHEDULE 13D
- Filed: 2025-05-14
- Accepted by EDGAR: May 14, 2025, 14:59 ET
- Period: not reported
- Accession: 0001213900-25-043211
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1107421/000121390025043211/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1107421/000121390025043211/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1107421/000121390025043211/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-043211. Last ingested by Listed: Nov 15, 2026, 00:22 ET. No prices; not investment advice.